- Home
- Applications
- transcranial
Refine by
Transcranial Product Applications
13 applications found
Transcranial magnetic stimulation is effective in treating major depression with minimal side effects reported. ...
BySYNEIKA based in 35000, FRANCE
Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique where pulses of electromagnetic fields target and interact with specific brain regions. ...
ByNexstim Plc based in Helsinki, FINLAND
Deep Transcranial Magnetic Stimulation, or Deep TMS, has been shown to safely and effectively alleviate the symptoms of obsessive-compulsive disorder (OCD), particularly those patients who have not achieved sufficient improvement from traditional OCD treatment ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) is a safe and effective aid for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
This system is instrumental for transcranial ultrasound localization microscopy (ULM), allowing for the imaging of the brain's microvasculature at a microscopic resolution, which is particularly beneficial for diagnosing and monitoring stroke and aneurysm. The system's current projects, in collaboration with entities like Geneva University and Physics for Medicine Paris, include developing transcranial ULM scanners for adults and creating implantable probes capable of continuous ...
ByIconeus based in Paris, FRANCE
Deep Transcranial Magnetic Stimulation (Deep TMS™) is the only TMS system FDA-cleared to safely and effectively reduce comorbid anxiety symptoms in adult patients with depression, also known as anxious ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Nexstim SmartFocus® nTMS mapping offers you the chance to improve outcomes and your patients’ quality of life. The clinical value of using the NBS System with SmartFocus® e-field navigated TMS technology has been firmly established, with over 100 papers on over 4,100 patients published ...
ByNexstim Plc based in Helsinki, FINLAND
Anti-psychotic medications are often effective for the positive symptoms of schizophrenia, and allow many patients to lead normal lives. However, many patients suffer from negative symptoms, which include inexpressiveness, deficits in cognitive and emotional skills, and lethargy. To date, the FDA has not approved any drug for the treatment of the negative symptoms of schizophrenia, and from the clinical data available it does not appear as though existing drugs – even new generation drugs – represent a ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in a person’s mood, energy, and ability to function. Different from the normal ups and downs that everyone goes through, the symptoms of bipolar disorder are severe. They can result in damaged relationships, poor job or school performance, and even suicide. About 5.7 million American adults or about 2.6 percent of the population aged 18 and older in any given year, have bipolar ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Post-traumatic stress disorder (PTSD) is an extreme anxiety response to a life-threatening situation, which often manifests as a tendency to avoid places or events that could remind patients of the traumatic experience, and which may impair patients’ quality of life for years, as well as their ability to function normally in daily ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Stroke represents one of the largest medical challenges facing our society today. In the U.S., someone has a stroke every 40 seconds and every four minutes someone will die as a result of stroke. Stroke is the 5th leading cause of death in the U.S. and the 2nd leading cause of death worldwide. In the U.S. stroke kills approximately 130,000 people each year (roughly 1 in every 20 deaths). Nearly 800,000 people have a stroke in the U.S. each year and approximately 87% are classified as ischemic (the result of a ...
ByCerevast Medical, Inc. based in Bothell, WASHINGTON (USA)
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
A revolutionary depression treatment that has changed the field of mental healthcare, Deep TMS has been FDA-cleared to safely and effectively treat Major Depressive Disorder through BrainsWay’s patented H-coil ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)